Möchten Sie immer auf dem neuesten Stand bleiben?

Please dial in at one of the following numbers a few minutes before the start of the conference call: From Sweden: +46 (0) 8 505 564 74 From the US: +1 855 753 22...

Vänligen ring in på något av följande telefonnummer några minuter före telefonkonferensens start: Från Sverige: +46 (0) 8 505 564 74 Från USA: +1 855 753 22 30 Från Storbritannien: +44...

Dr. Scharschmidt most recently served as Senior Vice President and Chief Medical & Development Officer at Hyperion Therapeutics (acquired by Horizon Pharma Inc. in 2015), where he was...

KDev Investments, an investment fund jointly owned by Karolinska Development and Rosetta Capital, will transfer all its shares in Clanotech to Rosetta Capital. Karolinska Development retains an...

KDev Investments AB, ett investmentbolag gemensamt ägt av Karolinska Development och Rosetta Capital, överför hela sitt innehav i Clanotech till Rosetta Capital. Karolinska Development bibehåller...

“I am delighted to welcome Chris to Aprea,” said Bernd R. Seizinger, M.D., Ph.D., Chairman of the Board of Directors.  “He is an accomplished biopharmaceutical executive with proven experience...

Dilaforette’s submission is entitled: ‘Sevuparin Demonstrates Binding to Key Adhesion Receptors Involved in Pathogenesis of Sickle-Cell Disease’ under session for non-malignant hematopoetic...

“We are very pleased with our collaboration with Cadila Pharmaceuticals, which will enable us to bring this important psoriasis product to the market”, said Dr. Anders Carlsson, CEO of Lipidor...

Profit and loss statement and the balance sheet: It was resolved to adopt the profit and loss statement and the balance sheet and the consolidated profit and loss statement and the consolidated...

Redovisning: Beslöts att fastställa resultat- och balansräkningen samt koncernredovisningen och koncernbalansräkningen. Resultatdisposition: Beslöts att godkänna styrelsens och verkställande...